Quest Diagnostics Incorporated

DGX

$206.87

Name : Quest Diagnostics Incorporated

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $23,012,706,304.00

EPSttm : 8.75

Quest Diagnostics Incorporated

$206.87

0.00%

$0.00999

Float Short %

5.26

Margin Of Safety %

Put/Call OI Ratio

1.25

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.8

Price

206.6

Target Price

218.73

Analyst Recom

2.17

Performance Q

10.72

Relative Volume

1.25

Beta

0.65

Ticker: DGX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-15	DGX	190.21	0.72	0.75	11249
2026-01-16	DGX	189.52	0.72	1.05	11325
2026-01-20	DGX	189.38	0.89	0.57	9422
2026-01-21	DGX	184.62	0.88	15.05	9521
2026-01-22	DGX	182.27	0.98	3.75	10057
2026-01-23	DGX	181.06	1.04	3.63	10289
2026-01-26	DGX	182.54	1.04	0.55	10325
2026-01-27	DGX	184.24	1.03	0.54	10366
2026-01-28	DGX	182.73	1.03	0.88	10374
2026-01-29	DGX	182.27	1.03	84.22	10398
2026-01-30	DGX	186.87	1.00	8.22	10210
2026-02-02	DGX	184.95	0.97	0.06	10134
2026-02-04	DGX	189.17	0.92	0.02	10464
2026-02-05	DGX	192.29	0.85	0.08	10915
2026-02-06	DGX	190.72	0.81	0.03	11315
2026-02-09	DGX	191.59	0.81	1.30	11258
2026-02-10	DGX	205.31	0.85	0.31	12476
2026-02-11	DGX	209.18	0.84	0.85	13647
2026-02-12	DGX	206.82	0.81	20.32	15128
2026-02-13	DGX	206.88	1.25	0.45	18825
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-15	DGX	190.23	5.8	235.7	9.81
2026-01-16	DGX	189.49	5.8	204.4	9.81
2026-01-20	DGX	189.03	5.8	206.7	9.81
2026-01-21	DGX	184.52	5.8	177.6	9.81
2026-01-22	DGX	182.19	5.8	191.7	9.81
2026-01-23	DGX	181.06	5.8	201.7	9.81
2026-01-26	DGX	182.61	5.8	222.2	9.81
2026-01-27	DGX	184.27	5.8	223.2	9.81
2026-01-28	DGX	182.49	5.8	197.0	9.81
2026-01-29	DGX	182.30	5.8	206.7	9.81
2026-01-30	DGX	186.93	5.8	244.6	9.81
2026-02-02	DGX	184.96	5.8	194.7	9.81
2026-02-03	DGX	185.17	5.8	211.3	9.81
2026-02-04	DGX	189.18	5.8	239.9	9.81
2026-02-05	DGX	192.30	5.7	232.6	9.81
2026-02-06	DGX	190.79	5.7	199.1	9.81
2026-02-09	DGX	191.48	5.7	215.7	9.81
2026-02-10	DGX	205.22	5.7	311.6	9.81
2026-02-11	DGX	209.33	11.1	237.4	10.60
2026-02-12	DGX	206.87	11.1	193.5	10.60
2026-02-13	DGX	206.60	6.7	208.3	10.63
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-15	DGX	-18.86	-0.92	5.28
2026-01-16	DGX	-18.86	-0.92	5.28
2026-01-20	DGX	-18.86	-0.85	5.28
2026-01-21	DGX	-18.86	-0.85	5.28
2026-01-22	DGX	-18.86	-0.85	5.28
2026-01-23	DGX	-18.86	-0.85	5.28
2026-01-26	DGX	-18.86	-0.88	5.28
2026-01-27	DGX	-18.86	-0.88	5.28
2026-01-28	DGX	-18.86	-0.88	5.17
2026-01-29	DGX	-18.86	-0.88	5.17
2026-01-30	DGX	-18.86	-0.88	5.17
2026-02-02	DGX	-17.49	-1.64	5.17
2026-02-03	DGX	-17.49	-1.64	5.17
2026-02-04	DGX	-17.49	-1.64	5.17
2026-02-05	DGX	-17.49	-1.64	5.17
2026-02-06	DGX	-17.49	-1.64	5.17
2026-02-09	DGX	-16.75	-0.13	5.17
2026-02-10	DGX	-16.75	-0.13	5.17
2026-02-11	DGX	-16.75	-0.13	5.26
2026-02-12	DGX	-17.51	-0.13	5.26
2026-02-13	DGX	-17.51	-0.13	5.26
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

2.36

Avg. EPS Est. Next Quarter

2.85

Insider Transactions

-17.51

Institutional Transactions

-0.13

Beta

0.65

Average Sales Estimate Current Quarter

2826

Average Sales Estimate Next Quarter

2948

Fair Value

219.23

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

3.1

Max Drawdown 5-Year %

-28.6

Target Price

218.73

P/E

23.63

Forward P/E

18.02

PEG

2.17

P/S

2.09

P/B

3.17

P/Free Cash Flow

16.93

EPS

8.76

Average EPS Est. Cur. Y

10.63

EPS Next Y. (Est.)

11.43

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.95

Relative Volume

1.25

Return on Equity vs Sector %

-14.8

Return on Equity vs Industry %

2.4

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.26

EBIT Estimation

208.3

Quest Diagnostics Incorporated

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 57000

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

stock quote shares DGX – Quest Diagnostics Incorporated Stock Price stock today

news today DGX – Quest Diagnostics Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch DGX – Quest Diagnostics Incorporated yahoo finance google finance

stock history DGX – Quest Diagnostics Incorporated invest stock market

stock prices DGX premarket after hours

ticker DGX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DGX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y